Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: Longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort

The Lancet Oncology

Volumn 12, Issue 6, 2011, Pages 551-558

  Chen, Li Sheng ^a   Yen, Amy Ming Fang ^a   Chiu, Sherry Yueh Hsia ^b   Liao, Chao Sheng ^c   Chen, Hsiu Hsi ^d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; FECES ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ADULT; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OCCULT BLOOD; PROSPECTIVE STUDIES; RISK; TAIWAN;

EID: 79957460150     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70101-2     Document Type: Article

References (22)

1. Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002, 9:99-103.
2. Grazzini G, Castiglione G, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 2004, 13:19-26.
3. Yang KC, Liao CS, Chiu YH, Yen MF, Chen THH Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. J Med Screen 2006, 13:8-13.
4. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244-255.
5. van Rossum LG, van Rijn AF, Laheij RJ, et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009, 101:1274-1281.
6. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009, 100:1103-1110.
7. Hol L, van Leerdam ME, van Ballegooijen M, et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010, 59:62-68.
8. Parra-Blanco A, Gimeno-García AZ, Quintero E, et al. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 2010, 45:703-712.
9. Zorzi M, Fedato C, Grazzini G, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2010, published online Dec 30. 10.1136/gut.2010.223982.
10. sive Droste JS Terhaar, Oort FA, van der Hulst RW, et al. Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers. Cancer Epidemiol Biomarkers Prev 2011, 20:272-280.
11. Neilson AR, Whynes DK Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med 1995, 41:365-374.
12. Kewenter J, Björk S, Haglind E, Smith L, Svanvik J, Ahrén C Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988, 62:645-651.
13. Hardcastle J Randomized control trial of faecal occult blood screening for colorectal cancer: results for the first 144,103 patients. Eur J Cancer Prev 1991, 1:1-21.
14. Jansen JH Participation in the first and second round of a mass-screening for colorectal cancer. Soc Sci Med 1984, 18:633-636.
15. Janda M, Hughes KL, Auster JF, Leggett BA, Newman BM Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting. J Gastroenterol Hepatol 2010, 25:1661-1667.
16. Choi KS, Jun JK, Lee HY, Hahm MI, Oh JH, Park EC Increasing uptake of colorectal cancer screening in Korea: a population-based study. BMC Public Health 2010, 10:265.
17. Chen THH, Chiu YH, Luh DL, et al. Taiwan Community-based Integrated Screening Group. Community-based multiple screening model: design, implementation, and analysis of 42 387 participants. Cancer 2004, 100:1734-1743.
18. Chiu YH, Chen LS, Chan CC, et al. Health information system for community-based multiple screening in Keelung, Taiwan (Keelung Community-based Integrated Screening No 3). Int J Med Inform 2006, 75:369-383.
19. Bureau of Health Promotion Annual Report 2007 Bureau of Health Promotion, Department of Health ROC TaiwanDepartment of Health ROC Taiwan, (accessed March 17, 2011). http://www.bhp.doh.gov.tw/BHPnet/Portal/StatisticsShow.aspx?No=200911300001.
20. Chen LS, Liao CS, Chang SH, Lai HC, Chen THH Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen 2007, 14:191-199.
21. Barrows GH, Burton RM, Jarrett DD, Russell GG, Alford MD, Songster CL Immunochemical detection of human blood in feces. Am J Clin Pathol 1978, 69:342-346.
22. Goto N, Fujimoto M, Ito K, et al. Basic study of OC-Sensor μ, a compact fully automated immunochemistry analyser for faecal occult blood tests. J Clin Lab Instruments Reagents 2002, 25:57-62.